loadpatents
Patent applications and USPTO patent grants for Burris; Thomas.The latest application filed is for "lxr inverse agonists for treatment of cancer".
Patent | Date |
---|---|
Compositions and methods of treating cardiac hypertrophy and heart failure Grant 11,389,427 - Zhang , et al. July 19, 2 | 2022-07-19 |
Lxr Inverse Agonists For Treatment Of Cancer App 20200308135 - BURRIS; Thomas ;   et al. | 2020-10-01 |
Err Inverse Agonists App 20200247792 - Kind Code | 2020-08-06 |
Compositions And Methods Of Treating Cardiac Hypertrophy And Heart Failure App 20190374507 - Zhang; Lilei ;   et al. | 2019-12-12 |
Modulators of the nuclear hormone receptor ROR Grant 9,586,928 - Kamenecka , et al. March 7, 2 | 2017-03-07 |
Modulators Of The Nuclear Hormone Receptor Ror App 20140187554 - Kamenecka; Theodore Mark ;   et al. | 2014-07-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.